PFBT
CRMD icon

Parkside Financial Bank & Trust’s CorMedix CRMD Stock Holding History

Parkside Financial Bank & Trust’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1
Closed -$7 – 2726
2026
Q1 		$7 Hold
1
– – ﹤0.01% 2684
2025
Q4 		$12 Hold
1
– – ﹤0.01% 2674
2025
Q3 		$12 Sell
1
-35
-97% -$423 ﹤0.01% 2698
2025
Q2 		$444 Sell
36
-29
-45% -$320 ﹤0.01% 2603
2025
Q1 		$400 Buy
+65
New +$673 ﹤0.01% 2539

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Parkside Financial Bank & Trust's CRMD Position: Q2 2026 in Review

Parkside Financial Bank & Trust sold out of CorMedix (CRMD) in Q2 2026, closing a stake of 1 share — an estimated $7 sold.

Parkside Financial Bank & Trust first reported a position in CRMD in Q1 2025 and held it in 5 quarters. The position peaked at $444 in Q2 2025. 193 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Parkside Financial Bank & Trust reported no remaining CorMedix position as of Q2 2026 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 1 CorMedix share in Q2 2026, an estimated $7.
  • Parkside Financial Bank & Trust first reported a position in CorMedix in Q1 2025 and held it in 5 quarters.
  • Parkside Financial Bank & Trust's CorMedix position peaked at $444 in Q2 2025.
  • 193 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.